Clinical trials
Completed Observational Multiple Sclerosis, Chronic Progressive trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
31 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 4 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 4 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 31 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 5 |
| Bayer | 3 |
| Novartis | 3 |
| State University of New York at Buffalo | 2 |
| Danish Research Centre for Magnetic Resonance | 1 |
| Duke University | 1 |
| Genzyme, a Sanofi Company | 1 |
| Icahn School of Medicine at Mount Sinai | 1 |
| Imperial College London | 1 |
| John F. Foley, MD | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Sclerosis, Chronic Progressive | 31 |
| Multiple Sclerosis, Relapsing-Remitting | 16 |
| Multiple Sclerosis | 13 |
| Autoimmune Diseases | 2 |
| Carcinoma in Situ | 1 |
| Demyelinating Diseases | 1 |
| Disease Progression | 1 |
| Immune System Diseases | 1 |
| Nerve Degeneration | 1 |
| Nervous System Diseases | 1 |
Trials
Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.